GH
AIMT

GAM Holding’s Aimmune Therapeutics AIMT Stock Holding History

GAM Holding’s Portfolio AIMT Stock Details AIMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-25,700
Closed -$885K – 365
2020
Q3 		$885K Buy
+25,700
New +$547K 0.05% 245

GAM Holding's AIMT Position: Q4 2020 in Review

GAM Holding sold out of Aimmune Therapeutics (AIMT) in Q4 2020, closing a stake of 25,700 shares — an estimated $885K sold.

GAM Holding first reported a position in AIMT in Q3 2020 and held it in 1 quarter. The position peaked at $885K in Q3 2020. 0 funds tracked by Wall St. Rank hold AIMT as of Q4 2020.

  • GAM Holding reported no remaining Aimmune Therapeutics position as of Q4 2020 after selling out during the quarter.
  • GAM Holding sold 25,700 Aimmune Therapeutics shares in Q4 2020, an estimated $885K.
  • GAM Holding first reported a position in Aimmune Therapeutics in Q3 2020 and held it in 1 quarter.
  • GAM Holding's Aimmune Therapeutics position peaked at $885K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q4 2020.

Based on GAM Holding's 13F filing for Q4 2020, filed 10 Feb 2021.